Reig saw accelerated sales across all divisions Q3 numbers showed a strong improvement in sales of the 3 divisions, with above 27% growth in Q3. Pharma Technologies grew 33%, helped by higher capacity utilisation in Barcelona, plus some revenues from the agreement with the EU for vaccine reserve capacity. Specialty pharma posted 40% growth, with a particular contribution from the osteoarticular division, while Consumer healthcare posted 6% growth despite the tougher comparison. Net debt short t ....